HSJ Medicines Forum 2026
13 October 2026
Hilton Tower Bridge, London, United Kingdom
The HSJ Medicines Forum is a one-day, senior-level forum for NHS leaders including policymakers, chief pharmacists, system executives and clinical leaders, focused on translating national reform under the 10-Year Health Plan into local delivery. Through keynotes, panel discussions and interactive roundtables it covers access to medicines, value from high-cost and innovative therapies, medicines in neighbourhood care models, and the use of data and digital in prescribing. Attendance is fully funded by HSJ for NHS delegates.
17 sessions · 32 speakers
Organiser (1)
Sponsors (3)
Roche · Menarini Group · GSK
Speakers (32)
- Jack Serle Senior Correspondent, HSJ Information
- Adrian Hayter Chief Medical Officer, NICE
- John Spoors Deputy Director of Medicines Evaluation, NICE
- Yousaf Ahmad ICS Chief Pharmacist, NHS Thames Valley
- Ben Williams Operations Director, Movianto UK
- Dr Sanaz Baheran R&D Project & Commercial Manager, Aspire Pharma Limited
- Jason Whaley Accounts Director - Key Account, Movianto UK
- Kieran Brown Engagement Manager, HSJ Information
- Llywelyn Cadman-Davies Lead Pharmacist - Myeloid Neoplasms; Clinical Lead for Haematology, Guy’s and St Thomas’ NHS Foundation Trust (GSTT)
- Suzanne Al-Rawi Pharmacist, NHS
- Yasmin Zobedey NHS Strategy, Portfolio and Partnerships Senior Manager, GSK
- Bhavana Reddy Head of Pharmacy and Clinical Support, Medicines Access and Value, NHS England (National)
- Claire Foreman Director of Medicines Policy & Strategy, NHS England
- Conor Price Chief Executive Officer, Community Pharmacy London, Coventry & Warwickshire and Herefordshire & Worcestershire
- Julian Beach Executive Director for Healthcare, Quality and Access, MHRA
- Luvjit Kandula Chair - GM Primary Care Board and Director of Strategy and Transformation CPGM, CPGM
- Mark Samuels Chief Executive Officer, Medicines UK
- Matt Greening Business Development Manager, B.Braun Medical
- Nitin D'Souza Head of Sales, Movianto UK
- Rahul Singal Chief Pharmacy Information Officer, NHS England - Technology, Digital and Data
- Richard Cattell Deputy Chief Pharmaceutical Officer, NHS England
- Richard Condon Chief Executive Officer, Aspire Pharma Limited
- Shilpa Shah Chief Executive Officer, Community Pharmacy North East London
- Shivam Maini Strategic Head of Medicines and Pharmacy, North East and North Cumbria ICB
- Susanne Lynch MBE Chief Pharmacist, NHS Cheshire and Merseyside ICB
- Tase Oputu President, Royal College of Pharmacy
- Uzo Ibechukwu Director of Pharmacy & Medicines Optimisation, Royal United Hospitals Bath NHS Foundation Trust
- Vanessa Burgess Chief Pharmacist, South East London ICB
- Vicky Chaplin Senior Clinical Lead, NHS England
- Vicky Damani Clinical Product Lead, First Databank UK
- Victoria Jordan Executive Director Patient Access, ABPI
- Darryl Masters Head of Hospitals - UK, Consilient Health (UK) Ltd
Agenda
- Opening remarks from the chair 13 October 2026 · Thames Suite
- Fireside Chat: Medicines as a Strategic Driver of NHS Performance, Productivity and Prevention 13 October 2026 · Thames Suite
- PANEL: A Whole-System Approach to Medicines: Policy, Pricing and Partnership 13 October 2026 · Thames Suite
- PANEL: From Strategy to Action: Medicines Leadership, Commissioning and Accountability in an Evolving NHS 13 October 2026 · Thames Suite
- Interactive Discussion Group 3: Delivering Healthcare Beyond the Hospital Walls 13 October 2026 · Thames Suite
- Interactive Discussion Group 2: Beyond the green light: Understanding why innovations may be slow to embed in NHS practice 13 October 2026 · Thames Suite
- Interactive Discussion Group 5: Ready to Administer Medicines: The licensed ready-to-administer medicines adoption gap - why proven innovations struggle to scale 13 October 2026 · Thames Suite
- Interactive Discussion Group 4: Choosing for Value: Aligning Medicines Decisions with NHS Productivity 13 October 2026 · Thames Suite
- Interactive Discussion Group 1: Who owns deprescribing? Governance, time, and the case for system-wide change 13 October 2026 · Thames Suite
- PANEL: Managing Medicines Value Across the Lifecycle: Innovation, Affordability and Sustainability 13 October 2026 · Thames Suite
- Innovation Showcase: Case Study 1: Licensed Ready-to-Administer & Ready-to-Use Medicines: Supporting Capacity, Resilience and Patient Care in the NHS 13 October 2026 · Thames Suite
- Innovation Showcase: Case study 2: Underpinning UK Health Security - How Public-Private Partnership Keeps the Nation's Medicines Moving 13 October 2026 · Thames Suite
- Innovation Showcase: Case study 3: Updates and next steps for genomics informed medicines optimisation 13 October 2026 · Thames Suite
- PANEL: Building the Infrastructure for Next-Generation Medicines Management 13 October 2026 · Thames Suite
- PANEL: Care Closer to Home: The Role of Neighbourhoods in Medicines Delivery 13 October 2026 · Thames Suite
- DEBATE: Delivering Innovation Within Financial Reality: How Can the NHS Pragmatically Implement New Medicines? 13 October 2026 · Thames Suite
- Closing remarks from the chair 13 October 2026 · Thames Suite